Patents/Assignees

Regulus Therapeutics Inc.

2 patents in portfolio

US12559750utility2026
Methods and Compositions for Treatment of Polycystic Kidney Disease
0 cites
US12005120utility2024
Galnac Conjugated Modified Oligonucleotides as Mir-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-effect
0 cites